PATIENTS AND METHODS
A total of 298 patients with NSTEMI (median age, 64 years; 85 women) were enrolled to this study. Local (carotid) arterial stiffness and IMT were measured noninvasively before discharge and after 12 months of contemporary pharmacological treatment according to current clinical guidelines. The study group was divided into patients with normal systolic blood pressure (BP) (<140 mm Hg) and those with increased systolic BP (≥140 mm Hg) at 12 months. The results were presented as median (25th-75th percentile).
RESULTS There were no significant changes in local arterial stiffness between patients with normal and those with increased systolic BP (8.9 m/s [7.9-10 . Arterial stiffness and IMT were affected by age and mean BP; however, adjustment for these variables did not affect the obtained results in multivariate models.
CONCLUSIONS The 1 -year pharmacological treatment of patients after NSTEMI was associated with a significant reduction in IMT but had no effect on the properties of the arterial structure.
times on each cardiac cycle. The average is calculated for each cardiac cycle. The local stiffness of the arterial wall is expressed as QAS = local pulse wave velocity (PWV): where: D = diastolic diameter, ∆D = change of diameter in systole, DC = distensibility coefficient, ∆p = local pulse pressure, and ρ = blood density. of the patients still received ACEI (P <0.0001) and 6%-ARB (P = 0.1); 91% of the patients received β -blocker (P = 0.8); 99%, statin (P = 0.01); 26%, diuretic (P = 0.9); and 27%, aldosterone antagonist (P = 0.4).
Hemodynamic parameters and arterial function and structure The analysis of hemodynamic data performed in all patients showed that systolic, diastolic, and mean BP were significantly higher at 12 months (TABLE 3) , although the median values of systolic and diastolic BP were within the reference current multiple drug therapy on the indices of arterial structure and function in an unselected "real -world population" of patients with established atherosclerotic heart disease. Therefore, we assessed whether a 12 -month treatment according to current guidelines 13 for secondary prevention of myocardial infarction (MI) affects arterial stiffness and IMT in consecutive patients admitted with the diagnosis of acute coronary syndrome (ACS).
PATIENTS AND METHODS Study population
The study included consecutive patients who were admitted for percutaneous coronary intervention due to ACS manifesting as NSTEMI within 12 hours from symptom onset and who presented more than 50% of coronary artery narrowing. Subjects with cardiogenic shock, advanced and refractory chronic heart failure, atrial fibrillation or flutter, chronic renal disease on dialysis, and known neoplasm or chronic condition with life expectancy of less than 1 year were excluded from the study. For the purpose of this study, blood pressure (BP) measurements and ultrasound assessments were performed between 48 and 72 hours after admission, and then at 12 -month follow -up in all patients who survived. Patients were discharged with a detailed description of their medical record and prescribed medication.
13
Further treatment was supervised by their family physician. The University Ethics Committee approved the study protocol, and written informed consent was obtained from all participants.
Blood pressure, local carotid stiffness, and intima--media thickness In all patients, brachial BP was measured using an oscillometric method (M -785; Omron Healthcare Company, Limited, Kyoto, Japan) in the supine position, after a 5 -minute rest, on both arms. The higher reading from one of the arms was taken for further analysis. The BP results were obtained from a single measurement on each arm. All patients underwent an ultrasound examination of the left common carotid artery, using high -resolution 4-13 MHz linear probe (MyLabClass C, Esoate, Genova, Italy). All investigations were performed with the patient in the supine position with head elevation. The common carotid artery 1 cm before the bulb was used for measurements. All measurements were performed with the dedicated ArtLab software using radiofrequency data technology (QIMT RF for IMT and QAS RF for arterial stiffness, Esoate, Genova, Italy). The QIMT algorithm allows the automatic detection of IMT, and real time feedback helps obtain the best possible measurements (with SD <20 µm); 6 successive measurements are continuously averaged. For the measurements of quality arterial stiffness (QAS), the left common carotid artery image 1 cm before bifurcation is obtained. The system cyclically computes 6 successive measurements of both the arterial distension and diameter (with SD <35 µm). The vessel distension and diameters are measured several the IMT was significantly reduced in comparison with the baseline values. In contrast, patients with a systolic BP of less than 140 mm Hg at the follow--up visit showed a nonsignificant difference in systolic and mean BP. Moreover, the QAS did not differ significantly, while the IMT was significantly reduced in comparison with the baseline value. Cholesterol concentrations were significantly lower in both subgroups in comparison with baseline data. Additionally, we analyzed the arterial structure and function in patients with previous MI versus those with no previous MI. No significant differences were shown either for the IMT or for QAS (data not shown).
In the whole study group, the QAS correlated significantly with systolic BP and age (r = 0.47, P <0.0001 and r = 0.43, P <0.0001, respectively; TABLE 5). Similarly, the IMT correlated significantly with age and systolic BP (r = 0.2, P <0.0001 and r = 0.2, P <0.0001, respectively; TABLE 5 ). Further analysis demonstrated that when the mean arterial stiffness was adjusted for age and mean BP, it did not differ significantly from the baseline value in any of the subgroups (FIGURE 1A). In contrast, the mean IMT adjusted for age and mean BP remained significantly lower compared with the baseline values in both subgroups (FIGURE 1B).
In a multivariate regression model with clinical characteristics obtained on enrollment, only age and BP significantly affected the IMT (data not shown). DISCUSSION Our study demonstrated that treatment according to the current guidelines had no significant effect on local arterial stiffness but was associated with a significant decrease in IMT in patients with NSTEMI.
Patients with established coronary heart disease are strongly encouraged to implement lifestyle changes that affect modifiable risk factors such as obesity, physical inactivity, or smoking. Moreover, treatment with aspirin or other antiplatelet drugs, statins, ACEIs or ARBs, and β -blockers also has proven benefit in secondary prevention of future CV complications. 13 The mechanisms by which these drugs exert beneficial effects are not fully understood and most probably are not limited to simple reduction of BP and cholesterol levels.
In recent years, particular interest was focused on new CV risk factors such as arterial stiffness and IMT. Several studies have demonstrated that increased arterial stiffness can predict CV complications, such as MI, stroke, or need for revascularization. 14 It is also regarded as a measure of target organ damage in patients with hypertension.
15-17
Stiffness can be measured at different arterial locations including the carotid -femoral segment or locally on the carotid or femoral artery. Moreover, general indices of arterial stiffness such as systemic arterial compliance or stiffness index derived from digital volume plethysmography are also used in clinical practice. 18 These different indices underscore that stiffness is not uniformly ranges. Similarly, local arterial stiffness of the carotid artery was significantly higher at 12 months. In contrast, the IMT and cholesterol concentrations were significantly reduced at 12 months.
Clinical, hemodynamic, and arterial parameters measured during the follow -up visit at 12 months in patient groups divided according to BP are shown in 9 showed that olmesartan improves segmental arterial stiffness and lowers central systolic and ambulatory BP in patients with metabolic syndrome. It should be noted that various populations with different risk profiles were represented in the above studies. Moreover, local versus segmental arterial stiffness was estimated, and short (6 weeks) versus long -term (7 months) drug treatment was applied. distributed along the arteries. Moreover, these various parameters have different associations with incident CV complications.
A comprehensive assessment of various indices of arterial stiffness with incidence of CV events and all -cause mortality showed that local carotid and femoral stiffness were independently associated with CV sequelae, including death. 19 It was also hypothesized that modification of arterial stiffness may influence future CV events. Studies performed so far have reported conflicting results on the effect of antihypertensive treatment on arterial stiffness. Mourad et al 20 reported that age -related increase in pulse pressure (surrogate Abbreviations: QIMT, quality intima-media thickness; others, see TABLE 3 it determines mean arterial transmural pressure, which in turn determines arterial stiffness. We noted that after adjustment for both explanatory variables, arterial stiffness did not differ significantly at 12 months in any of the subgroups. Several randomized controlled trials demonstrated that lipid -modifying therapy delays the annual rate of change in IMT or leads to its reduction. [23] [24] [25] Despite differences in ultrasound assessment of IMT across clinical trials, there is a consistent finding of a relationship between the rate of change of this marker and lipid--lowering therapy. Moreover, there is evidence that such treatment affects clinical endpoints. IMT is affected not only by lipid -lowering drugs. The Diabetes Interventions and Complications Research Group demonstrated that intensive type 1 diabetes treatment resulted in decreased progression of IMT 6 years after the study.
26 It is well known that hypertension promotes carotid intima -media thickening. Wang et al 11 performed a meta -analysis of randomized controlled trials that evaluated the effects of antihypertensive drugs versus placebo on carotid IMT. It was shown that ACEIs, ARBs, or calcium channel blockers decreased intima-media thickening in the presence In our current study, 298 survivors of NSTEMI were evaluated after 12 months of treatment according to the guidelines. Most of the patients received the most contemporary pharmacological treatment at discharge and the majority of the patients continued it throughout the 12 -month follow -up. Local carotid arterial stiffness was estimated by echo -tracking. After 12 months of treatment, median systolic and diastolic BP were significantly higher (although within the reference ranges), and local arterial stiffness was also significantly higher in comparison with the baseline values. The study population was further subdivided into those with a systolic BP of less than 140 mm Hg and of 140 mm Hg or higher at follow--up visit at 12 months. Arterial stiffness was significantly (borderline) higher in patients with higher systolic BP at the follow -up visit. This population also more often suffered from hypertension in the past. It is well known that arterial stiffness is correlated with age and BP. 21, 22 Similarly, in our study, arterial stiffness correlated strongly and significantly with age and BP. We therefore compared arterial stiffness in the subgroups after adjustment for both covariates. We used the mean arterial pressure in the model because of similar BP reduction. Our results support these findings. The IMT was significantly reduced at 12 months. Moreover, both subgroups showed a significant reduction in IMT. IMT correlates with patients' age and BP; therefore, we compared the results after adjustment for both covariates. We observed that IMT was significantly reduced after 12 months of treatment according to the guidelines, independently of both explanatory variables.
Taken together, our study demonstrated that contemporary drug treatment of the survivors of NSTEMI is associated with a reduction of the IMT and has no effect on arterial stiffness.
Our study has several limitations. We assessed local carotid stiffness but the obtained results at a particular arterial segment cannot be extrapolated to any other arterial location. Long -term effects of the treatment were estimated, theoretically involving arterial wall remodeling, but the role of reduced distension pressure cannot be excluded. Finally, most of the patients were treated with combination therapy, thus the obtained results are not attributable to any particular drug.
